INSM - Insmed Incorporated
NASDAQ
->
Healthcare
->
Biotechnology
Bridgewater,
United States
Type: Equity
INSM price evolution
INSM
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1246.8 | $595.73 | $482.37 | $487.11 |
| Short term investments | $298.07 | $298.84 | ||
| Net receivables | $40.3 | $37.16 | $41.19 | $35.58 |
| Inventory | $90.06 | $82.96 | $83.25 | $77.92 |
| Total current assets | $1418.18 | $758.72 | $929.06 | $926.58 |
| Long term investments | ||||
| Property, plant & equipment | $108.81 | $106.12 | $104.39 | $104.73 |
| Goodwill & intangible assets | $197.29 | $198.55 | $199.81 | $201.08 |
| Total noncurrent assets | $391.93 | $400.37 | $400.77 | $398.3 |
| Total investments | $298.07 | $298.84 | ||
| Total assets | $1810.12 | $1159.1 | $1329.84 | $1324.87 |
| Current liabilities | ||||
| Accounts payable | $290.84 | $189.36 | $214.99 | $187.78 |
| Deferred revenue | ||||
| Short long term debt | $233.31 | $231.5 | $10.64 | $8.95 |
| Total current liabilities | $524.15 | $420.86 | $225.63 | $196.73 |
| Long term debt | $1142.46 | $1136.18 | $1348.39 | $1341.68 |
| Total noncurrent liabilities | $1247.15 | $1203.04 | $1436.13 | $1417.5 |
| Total debt | $1375.76 | $1367.67 | $1359.03 | $1350.63 |
| Total liabilities | $1771.3 | $1623.9 | $1661.76 | $1614.23 |
| Shareholders' equity | ||||
| Retained earnings | -$3903.84 | -$3603.24 | -$3446.14 | -$3260.08 |
| Other shareholder equity | -$2.83 | -$1.64 | -$0.74 | -$2.08 |
| Total shareholder equity | $38.82 | -$464.81 | -$331.92 | -$289.36 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $482.37 | $1074.04 | $716.78 | $532.76 |
| Short term investments | $298.07 | $74.24 | ||
| Net receivables | $41.19 | $29.71 | $24.35 | $16.56 |
| Inventory | $83.25 | $69.92 | $67.01 | $49.59 |
| Total current assets | $929.06 | $1273.38 | $837.04 | $622.89 |
| Long term investments | $50.04 | |||
| Property, plant & equipment | $104.39 | $102.08 | $95.52 | $97.23 |
| Goodwill & intangible assets | $199.81 | $204.87 | $209.92 | $49.26 |
| Total noncurrent assets | $400.77 | $383.05 | $406.47 | $173.26 |
| Total investments | $298.07 | $74.24 | $50.04 | |
| Total assets | $1329.84 | $1656.43 | $1243.51 | $796.15 |
| Current liabilities | ||||
| Accounts payable | $214.99 | $52.61 | $35.78 | $42.85 |
| Deferred revenue | ||||
| Short long term debt | $10.64 | $8.13 | $10.14 | $12.56 |
| Total current liabilities | $225.63 | $190.24 | $135.17 | $118.81 |
| Long term debt | $1348.39 | $1154.89 | $602.13 | $392.29 |
| Total noncurrent liabilities | $1436.13 | $1378.24 | $697.87 | $401.46 |
| Total debt | $1359.03 | $1325.88 | $612.27 | $404.84 |
| Total liabilities | $1661.76 | $1568.48 | $833.04 | $520.27 |
| Shareholders' equity | ||||
| Retained earnings | -$3446.14 | -$2696.58 | -$2265.24 | -$1830.59 |
| Other shareholder equity | -$0.74 | $0.76 | $0.97 | $0.19 |
| Total shareholder equity | -$331.92 | $87.95 | $410.47 | $275.88 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $90.34 | $75.5 | $83.69 | |
| Cost of revenue | $20.96 | $17.46 | $18.44 | |
| Gross Profit | $69.38 | $58.04 | $65.25 | |
| Operating activities | ||||
| Research & development | $146.75 | $121.08 | $137.03 | |
| Selling, general & administrative | $106.57 | $93.1 | $89.53 | |
| Total operating expenses | $358.28 | $203.55 | $243.52 | |
| Operating income | -$288.9 | -$145.5 | -$178.27 | |
| Income from continuing operations | ||||
| EBIT | -$278.5 | -$135.46 | -$164.28 | |
| Income tax expense | $0.84 | $0.59 | $1 | |
| Interest expense | $21.27 | $21.04 | $20.78 | |
| Net income | ||||
| Net income | -$300.61 | -$157.09 | -$186.06 | |
| Income (for common shares) | -$300.61 | -$157.09 | -$186.06 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $305.21 | $245.36 | $188.46 | $164.41 |
| Cost of revenue | $65.57 | $55.13 | $44.15 | $39.87 |
| Gross Profit | $239.63 | $190.23 | $144.31 | $124.54 |
| Operating activities | ||||
| Research & development | $571.01 | $397.52 | $272.74 | $181.16 |
| Selling, general & administrative | $344.5 | $265.78 | $234.27 | $203.61 |
| Total operating expenses | $949.26 | $647.55 | $519.4 | $389.77 |
| Operating income | -$709.63 | -$457.32 | -$375.09 | -$265.23 |
| Income from continuing operations | ||||
| EBIT | -$665.32 | -$453.7 | -$395.94 | -$263.12 |
| Income tax expense | $2.56 | $1.38 | -$1.76 | $1.4 |
| Interest expense | $81.69 | $26.45 | $40.47 | $29.56 |
| Net income | ||||
| Net income | -$749.57 | -$481.53 | -$434.65 | -$294.09 |
| Income (for common shares) | -$749.57 | -$481.53 | -$434.65 | -$294.09 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$300.61 | -$157.09 | -$186.06 | -$158.93 |
| Operating activities | ||||
| Depreciation | -$2.21 | $9.37 | $3.52 | $3.88 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $23.29 | $21.45 | $19.98 | $19.99 |
| Total cash flows from operations | -$122.95 | -$184.03 | -$130.82 | -$136.33 |
| Investing activities | ||||
| Capital expenditures | -$6.78 | -$4.68 | -$2.15 | -$2.85 |
| Investments | $300 | $3.96 | $10 | |
| Total cash flows from investing | -$6.78 | $295.32 | $1.8 | $7.15 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $781.73 | $4.05 | $122.1 | $2.34 |
| Net borrowings | -$0.65 | -$0.62 | $1.17 | -$1.09 |
| Total cash flows from financing | $781.49 | $3.02 | $123.26 | $1.25 |
| Effect of exchange rate | -$0.69 | -$0.95 | $1.01 | $2.17 |
| Change in cash and equivalents | $651.07 | $113.36 | -$4.74 | -$125.77 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$749.57 | -$481.53 | -$434.65 | -$294.09 |
| Operating activities | ||||
| Depreciation | $19.79 | $22.31 | $14.18 | $14.15 |
| Business acquisitions & disposals | $3.42 | -$6.7 | ||
| Stock-based compensation | $74.78 | $57.69 | $46.02 | $36.16 |
| Total cash flows from operations | -$536.25 | -$400.44 | -$363.3 | -$219.35 |
| Investing activities | ||||
| Capital expenditures | -$13.29 | -$9.88 | -$7.29 | -$6.24 |
| Investments | -$213.73 | -$24.71 | -$50.29 | |
| Total cash flows from investing | -$223.6 | -$34.58 | -$64.28 | -$6.82 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $170.87 | $311.66 | $291.92 | $271.94 |
| Net borrowings | -$2.44 | $482.22 | $321.7 | -$0.94 |
| Total cash flows from financing | $168.44 | $793.27 | $612.55 | $271 |
| Effect of exchange rate | -$0.25 | -$1 | -$0.93 | $0.49 |
| Change in cash and equivalents | -$591.66 | $357.25 | $184.03 | $45.33 |
News
Fundamentals
| Market cap | $12.35B |
|---|---|
| Enterprise value | $12.48B |
| Shares outstanding | 166.67M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 296.49 |
| Book/Share | 0.25 |
| Cash/Share | 7.48 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -5.01 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.71 |
| Quick ratio | 2.53 |